Safety and effectiveness of apixaban compared to warfarin in dialysis patients

about

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

Item

http://www.wikidata.org/entity/Q56380572

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2018

@uk

name

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@en

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@nl

type

Item

label

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@en

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@nl

prefLabel

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@en

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@nl

P1476

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

@en

P2093

Daniel Reed

http://www.w3.org/2001/XMLSchema#string

Hillary Maitland

http://www.w3.org/2001/XMLSchema#string

Rebecca Hockman

http://www.w3.org/2001/XMLSchema#string

Sumner Abraham

http://www.w3.org/2001/XMLSchema#string

Surabhi Palkimas

http://www.w3.org/2001/XMLSchema#string

Tri Le

http://www.w3.org/2001/XMLSchema#string

P2860

Apixaban versus warfarin in patients with atrial fibrillation

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Apixaban in patients with atrial fibrillation.

Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates.

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis.

Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.

Uremic bleeding: pathophysiology and clinical risk factors.

Chronic kidney disease increases risk for venous thromboembolism

Vitamin K-dependent proteins, warfarin, and vascular calcification

P304

291-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/RTH2.12083

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30046731

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

P932

6055495

http://www.w3.org/2001/XMLSchema#string